drugset / Trial / NCT00621803

Lcr35 / ICU / P. Aeruginosa

NCT00621803

RandomizedParallel-groupDouble-blindTreatment

Summary

Preventing carriage of potentially pathogenic micro-organisms from the aerodigestive tract is an infection control strategy used to reduce the occurrence of nosocomial infections - including ventilator-assisted pneumonia - in intensive care units. The use of antibiotics is controversial and can lead to adverse effect such as the selection of highly resistant pathogens. The purpose of this study was to investigate the effect of oral administration of a probiotic strain, Lactobacillus, on gastric and respiratory tract colonisation/infection by Pseudomonas aeruginosa strains, according to the concept that an indigenous flora has a protective effect against secondary colonisation.

Timeline

Start
2003-03
Primary completion
2004-10
Completion
2005-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactobacillus casei rhamnosus Other / unclassified Oral